Form 4 · Filed Jun 1, 2026, 11:33 AM UTC
CMMB/Chemomab Therapeutics Ltd.
Mor George Adi — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 29, 2026 | P | buy | 4,878 | $2 | $10,000 | 134,205 |
| May 29, 2026 | P | buy | 4,926 | $2 | $10,246 | 139,131 |
| May 29, 2026 | J | other | 31,712 | — | — | 31,712 |
| May 29, 2026 | J | other | 18,750 | — | — | 18,750 |
Source: SEC EDGAR raw filing ↗ · Accession 0001178913-26-003004